ribavirin has been researched along with Atresia, Biliary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; de Ruiter, PE; Li, P; Pan, Q; Peppelenbosch, MP; van der Laan, LJW; Verstegen, MMA; Wang, Y; Yin, Y | 1 |
| Huysentruyt, K; Leclercq, G; Scheers, I; Smets, F; Sokal, EM; Stephenne, X; Varma, S | 1 |
| Jankowska, I; Pawłowska, J; Rokitka, M; Socha, J; Sokal, E; Teisseyre, M | 1 |
3 other study(ies) available for ribavirin and Atresia, Biliary
| Article | Year |
|---|---|
Rotavirus Infection and Cytopathogenesis in Human Biliary Organoids Potentially Recapitulate Biliary Atresia Development.
Topics: Antibodies, Neutralizing; Antigens, Viral; Antiviral Agents; Biliary Atresia; Capsid Proteins; Cytopathogenic Effect, Viral; Host Microbial Interactions; Humans; Interferon-alpha; Mycophenolic Acid; Organoids; Ribavirin; Rotavirus Infections | 2020 |
Sofosbuvir/ledipasvir and ribavirin tolerability and efficacy in pediatric liver transplant recipients.
Topics: Adolescent; Antiviral Agents; Benzimidazoles; Biliary Atresia; Budd-Chiari Syndrome; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Humans; Infant; Liver; Liver Cirrhosis; Liver Transplantation; Male; Recurrence; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Uridine Monophosphate | 2017 |
[Complications in a patient with liver cirrhosis and HCV coinfection during treatment with peginterferon and ribavirin].
Topics: Adolescent; Antiviral Agents; Biliary Atresia; Child; Female; Hepatitis C, Chronic; Humans; Hypertension, Portal; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Failure; Liver Transplantation; Polyethylene Glycols; Portasystemic Shunt, Transjugular Intrahepatic; Recombinant Proteins; Ribavirin; Treatment Outcome | 2005 |